Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline pathogenic variants in Asian American/Pacific Islander women with breast cancer.

American journal of surgery - 1 Mar 2026

Tang Annie, Schulz-Costello Katherine, Jones Veronica, Tseng Jennifer

Abstract excerpt

INTRODUCTION: In 2024, the American Cancer Society reported that Asian American/Pacific Islander (AAPI) women have a rising breast cancer incidence that has surpassed other ethnicities. We aimed to identify the prevalence of pathogenic variants (PV) in the AAPI population with breast cancer and the implications for treatment. METHODS: We conducted a prospective cohort study of AAPI women diagnosed with breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Germ-Line Mutation

Source

Identifiers

PMID: 41478001
DOI: 10.1016/j.amjsurg.2025.116786

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline pathogenic variants in Asian American/Pacific Islander women with breast cancer.PMID 41478001Read ↗

Prevalence of BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer.Semantic proximity Read ↗

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSemantic proximity Read ↗

Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System.Semantic proximity Read ↗

Extended Multigene Panel Testing in a High-Risk Brazilian Public Health Cohort: Pathogenic Variant Prevalence and the Role of Self-Reported EthnicitySemantic proximity Read ↗

Prevalence of BRCA1/BRCA2 pathogenic variation in Chinese Han population.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome.Semantic proximity Read ↗

Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.Semantic proximity Read ↗

Landscape of Germline Pathogenic Variants in Luminal Breast Cancer from an Under-Represented Southeast Asian PopulationsSemantic proximity Read ↗

Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian PatientsSemantic proximity Read ↗

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.Semantic proximity Read ↗

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.